Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late Boosts for ALVAC-HIV/AIDSVAX B/E in Thai Adults
NCT01931358Phase 2Unknown
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2013
- Primary completion
- Dec 2021
- Modality
- Prophylactic Vaccines, Viral Vectors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ALVAC-HIV, AIDSVAX B/E in human immunodeficiency virus infection (HIV), sponsored by U.S. Army Medical Research and Development Command. Status: unknown.
02
Drugs
ALVAC-HIVAIDSVAX B/E
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01931358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931358.